EPISODE · Aug 30, 2024 · 18 MIN
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
from JACC This Week
Neha J. Pagidipati, MD, FACC, JACC Associate Editor and Subodh Verma MD, PhD explore a secondary analysis of the SELECT trial, a landmark study investigating the cardiovascular benefits of semaglutide in people with obesity or overweight without diabetes.
Embed this episode
NOW PLAYING
Updates from the SELECT Trial: Outcomes by Sex | ESC 2024
0:00
18:56
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of JACC This Week?
This episode is 18 minutes long.
When was this JACC This Week episode published?
This episode was published on August 30, 2024.
Can I download this JACC This Week episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!